Opportunities and Limitations of Renal Denervation: Where Do We Stand?
Hypertension is a primary contributor to cardiovascular disease, and the leading risk factor for loss of quality adjusted life years. Up to 50% of the cases of hypertension in the US remain uncontrolled. Additionally, 8-18% of the hypertensive population have resistant hypertension, uncontrolled pressure despite three different anti-hypertensive agents. Recently, catheter-based, percutaneous renal denervation emerged as a method for ablating renal sympathetic nerves for difficult to control hypertension.
Source: The American Journal of Medicine - Category: General Medicine Authors: Beatriz Castillo Rodriguez, Eric A. Secemsky, Rajesh V. Swaminathan, Dmitriy N. Feldman, Markus Schlaich, Yuri Battaglia, Edward Filippone, Chayakrit Krittanawong Tags: Review Source Type: research
More News: Cardiology | Cardiovascular | General Medicine | Heart | Hypertension | Reflex Sympathetic Dystrophy